{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T13:17:50Z","timestamp":1783084670623,"version":"3.54.6"},"reference-count":122,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Renal dysfunction is highly prevalent among patients with cirrhosis and has major implications for management, prognostication, and liver transplant decision-making. Both acute kidney injury (AKI) and chronic kidney disease (CKD) occur frequently in this population and are driven by a complex interplay of hemodynamic derangements, systemic inflammation, and intrinsic or functional renal injury. Accurate assessment of kidney function is essential, as serum creatinine and estimated glomerular filtration rate (eGFR) calculations directly influence MELD-based transplant allocation, eligibility for simultaneous liver\u2013kidney transplantation (SLKT), and clinical decisions such as drug dosing and peri-transplant immunosuppression strategies. However, creatinine-based assessments are fundamentally limited in cirrhosis due to reduced creatinine production, sarcopenia, expanded volume of distribution, increased tubular secretion, and assay interference from hyperbilirubinemia, resulting in frequent overestimation of true GFR. Alternative methods, including cystatin C-based equations, combined creatinine\u2013cystatin C equations, timed urine clearances, and direct GFR measurement using exogenous filtration markers (iohexol, iothalamate), offer potential advantages but also carry important limitations, particularly in decompensated disease with ascites or inflammation. Newer cirrhosis-specific eGFR equations such as the GRAIL and Royal Free Hospital formulas attempt to address these shortcomings, yet validation studies demonstrate inconsistent accuracy across patient cohorts. This review summarizes the pathophysiologic contributors to renal dysfunction in cirrhosis, evaluates the performance and pitfalls of existing kidney function assessment tools, and highlights the ongoing need for reliable, validated methods tailored to this unique population. Until improved approaches are widely accessible, serum creatinine remains the most practical\u2014albeit imperfect\u2014marker guiding clinical decision-making in cirrhotic patients.<\/jats:p>","DOI":"10.3390\/diagnostics16132088","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T11:39:11Z","timestamp":1783078751000},"page":"2088","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Kidney Function in Cirrhosis: Methods and Pitfalls"],"prefix":"10.3390","volume":"16","author":[{"given":"Fernando","family":"Gil-Lopez","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Mayo Clinic, Jacksonville, FL 32224, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7564-0844","authenticated-orcid":false,"given":"Namrata","family":"Parikh","sequence":"additional","affiliation":[{"name":"Division of Kidney and Pancreas Transplant, Department of Transplant, Mayo Clinic, Jacksonville, FL 32224, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Mai","sequence":"additional","affiliation":[{"name":"Division of Kidney and Pancreas Transplant, Department of Transplant, Mayo Clinic, Jacksonville, FL 32224, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razvan","family":"Chirila","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Mayo Clinic, Jacksonville, FL 32224, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4886-0897","authenticated-orcid":false,"given":"Hani M.","family":"Wadei","sequence":"additional","affiliation":[{"name":"Division of Kidney and Pancreas Transplant, Department of Transplant, Mayo Clinic, Jacksonville, FL 32224, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMra2215289","article-title":"Acute Kidney Injury in Patients with Cirrhosis","volume":"388","author":"Nadim","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1111\/j.1600-6143.2008.02426.x","article-title":"Kidney allocation to liver transplant candidates with renal failure of undetermined etiology: Role of percutaneous renal biopsy","volume":"8","author":"Wadei","year":"2008","journal-title":"Am. J. Transplant."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/TP.0000000000000215","article-title":"Renal outcomes of liver transplant recipients who had pretransplant kidney biopsy","volume":"98","author":"Wadei","year":"2014","journal-title":"Transplantation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.cgh.2010.03.029","article-title":"Incidence and prognosis of different types of functional renal failure in cirrhotic patients with ascites","volume":"8","author":"Montoliu","year":"2010","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1016\/j.cgh.2021.12.002","article-title":"2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis","volume":"20","author":"Le","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.cgh.2019.01.043","article-title":"Association Between Renal Function Pattern and Mortality in Patients with Cirrhosis","volume":"17","author":"Cullaro","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.cgh.2024.10.023","article-title":"Acute Kidney Injury in Patients with Cirrhosis and Chronic Kidney Disease: Results from the HRS-HARMONY Consortium","volume":"23","author":"Robinson","year":"2025","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1111\/liv.15198","article-title":"Assessment of glomerular filtration rate in patients with cirrhosis: Available tools and perspectives","volume":"42","author":"Campion","year":"2022","journal-title":"Liver Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/lt.26216","article-title":"Estimating Glomerular Filtration Rate in Cirrhosis Using Creatinine-Based and Cystatin C-Based Equations: Systematic Review and Meta-Analysis","volume":"27","author":"Singapura","year":"2021","journal-title":"Liver Transplant."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Attieh, R.M., and Wadei, H.M. (2023). Acute Kidney Injury in Liver Cirrhosis. Diagnostics, 13.","DOI":"10.3390\/diagnostics13142361"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199808203390807","article-title":"Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis","volume":"339","author":"Martin","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1476-5381.1993.tb13563.x","article-title":"Induction by endotoxin of nitric oxide synthase in the rat mesentery: Lack of effect on action of vasoconstrictors","volume":"109","author":"Mitchell","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/0168-8278(91)90920-7","article-title":"Increased circulating calcitonin gene-related peptide (CGRP) in cirrhosis","volume":"12","author":"Bendtsen","year":"1991","journal-title":"J. Hepatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0016-5085(98)70486-X","article-title":"Increased adrenomedullin levels in cirrhosis: Relationship with hemodynamic abnormalities and vasoconstrictor systems","volume":"114","author":"Guevara","year":"1998","journal-title":"Gastroenterology"},{"key":"ref_16","first-page":"35","article-title":"Plasma levels of substance P in liver cirrhosis: Relationship to the activation of vasopressor systems and urinary sodium excretion","volume":"21","author":"Prieto","year":"1995","journal-title":"Hepatology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1053\/jhep.2003.50304","article-title":"Increased carbon monoxide production in patients with cirrhosis with and without spontaneous bacterial peritonitis","volume":"38","author":"Fernandez","year":"2003","journal-title":"Hepatology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1478-3231.2009.02137.x","article-title":"Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis","volume":"30","author":"Caraceni","year":"2010","journal-title":"Liver Int."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jhep.2008.12.011","article-title":"Angiogenesis in liver disease","volume":"50","author":"Fernandez","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3748\/wjg.v16.i3.281","article-title":"Hypoxia, angiogenesis and liver fibrogenesis in the progression of chronic liver diseases","volume":"16","author":"Paternostro","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: Pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMra0809139","article-title":"Renal failure in cirrhosis","volume":"361","author":"Gines","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S2468-1253(24)00078-5","article-title":"Infections in cirrhosis","volume":"9","author":"Piano","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/hep.32049","article-title":"Malnutrition, Frailty, and Sarcopenia in Patients with Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"Lai","year":"2021","journal-title":"Hepatology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.3748\/wjg.v29.i27.4236","article-title":"Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota","volume":"29","author":"Maslennikov","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.cgh.2012.02.025","article-title":"Rifaximin improves systemic hemodynamics and renal function in patients with alcohol-related cirrhosis and ascites","volume":"10","author":"Kalambokis","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1007\/s10620-016-4313-0","article-title":"Rifaximin Decreases the Incidence and Severity of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis","volume":"61","author":"Dong","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/hep.28898","article-title":"Rifaximin has no effect on hemodynamics in decompensated cirrhosis: A randomized, double-blind, placebo-controlled trial","volume":"65","author":"Kimer","year":"2017","journal-title":"Hepatology"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Ichim, C., Boicean, A., Todor, S.B., Boeras, I., Anderco, P., and Birlutiu, V. (2026). Clinical and MicroRNA Responses to Fecal Microbiota Transplantation in Patients with Alcohol-Related Cirrhosis: A Pilot Study. Diagnostics, 16.","DOI":"10.3390\/diagnostics16060846"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Ichim, C., Boicean, A., Todor, S.B., Anderco, P., and Birlutiu, V. (2025). Fecal Microbiota Transplantation in Patients with Alcohol-Associated Cirrhosis: A Clinical Trial. J. Clin. Med., 14.","DOI":"10.3390\/jcm14175981"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/gut.2010.235473","article-title":"Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis","volume":"60","author":"Moller","year":"2011","journal-title":"Gut"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0168-8278(01)00175-1","article-title":"Blood volume distribution in patients with cirrhosis: Aspects of the dual-head gamma-camera technique","volume":"35","author":"Henriksen","year":"2001","journal-title":"J. Hepatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1053\/j.ajkd.2020.03.016","article-title":"Clinical Application of Kidney Biomarkers in Cirrhosis","volume":"76","author":"Allegretti","year":"2020","journal-title":"Am. J. Kidney Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2012.03.015","article-title":"Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis","volume":"57","author":"Fagundes","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jhep.2024.03.031","article-title":"Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting","volume":"81","author":"Nadim","year":"2024","journal-title":"J. Hepatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.ajkd.2013.07.017","article-title":"Kidney disease in the setting of liver failure: Core curriculum 2013","volume":"62","author":"Gonwa","year":"2013","journal-title":"Am. J. Kidney Dis."},{"key":"ref_37","first-page":"1408","article-title":"The role of duplex-doppler ultrasonography in the diagnosis of renal dysfunction and hepatorenal syndrome in patients with liver cirrhosis","volume":"51","author":"Kastelan","year":"2004","journal-title":"Hepatogastroenterology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jhep.2020.04.043","article-title":"Changing epidemiology and outcomes of acute kidney injury in hospitalized patients with cirrhosis\u2014A US population-based study","volume":"73","author":"Desai","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.jhep.2023.07.010","article-title":"Incidence and outcomes of acute kidney injury including hepatorenal syndrome in hospitalized patients with cirrhosis in the US","volume":"79","author":"Patidar","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1053\/j.gastro.2021.08.050","article-title":"MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era","volume":"161","author":"Kim","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cgh.2020.05.064","article-title":"Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States","volume":"19","author":"Younossi","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/lt.25694","article-title":"Chronic Kidney Disease in Liver Transplant Candidates: A Rising Burden Impacting Post-Liver Transplant Outcomes","volume":"26","author":"Cullaro","year":"2020","journal-title":"Liver Transplant."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/lt.25651","article-title":"Arterial Blood Pressure at Liver Transplant Evaluation Predicts Renal Histology in Candidates with Renal Dysfunction","volume":"25","author":"Wadei","year":"2019","journal-title":"Liver Transplant."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jhep.2019.07.002","article-title":"News in pathophysiology, definition and classification of hepatorenal syndrome: A step beyond the International Club of Ascites (ICA) consensus document","volume":"71","author":"Angeli","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2003.50016","article-title":"Model for end-stage liver disease (MELD) and allocation of donor livers","volume":"124","author":"Wiesner","year":"2003","journal-title":"Gastroenterology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","article-title":"Hyponatremia and mortality among patients on the liver-transplant waiting list","volume":"359","author":"Kim","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1053\/jhep.2002.33160","article-title":"Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation","volume":"35","author":"Nair","year":"2002","journal-title":"Hepatology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e3057","DOI":"10.1097\/MD.0000000000003057","article-title":"High Mortality of Cirrhotic Patients with End-Stage Renal Disease","volume":"95","author":"Hung","year":"2016","journal-title":"Medicine"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1053\/j.gastro.2018.07.025","article-title":"Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease-Sodium Scores on Patient Outcomes","volume":"155","author":"Nagai","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1002\/lt.25591","article-title":"Sarcopenia in Chronic Liver Disease: Impact on Outcomes","volume":"25","author":"Ooi","year":"2019","journal-title":"Liver Transplant."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e201129","DOI":"10.1001\/jamasurg.2020.1129","article-title":"Quantifying Sex-Based Disparities in Liver Allocation","volume":"155","author":"Locke","year":"2020","journal-title":"JAMA Surg."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1097\/TP.0000000000002196","article-title":"Reduced Access to Liver Transplantation in Women: Role of Height, MELD Exception Scores, and Renal Function Underestimation","volume":"102","author":"Allen","year":"2018","journal-title":"Transplantation"},{"key":"ref_53","unstructured":"(2026, May 28). Organ Procurement and Transplantation Network (OPTN). Liver Policy. OPTN Website, Available online: https:\/\/optn.transplant.hrsa.gov\/media\/3idbp5vq\/policy-guid-change_impr-liv-alloc-meld-peld-sta-1a-sta-1b_liv.pdf."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.transproceed.2021.04.001","article-title":"Basiliximab with Delayed Tacrolimus Improves Short-Term Renal Outcomes Post-Liver Transplantation-a Real-World Experience","volume":"53","author":"Boyd","year":"2021","journal-title":"Transplant. Proc."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.dld.2021.12.006","article-title":"Renal function after liver transplantation: Real-world experience with basiliximab induction and delayed reduced-dose tacrolimus","volume":"54","author":"Cederborg","year":"2022","journal-title":"Dig. Liver Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1681\/ASN.0000001040","article-title":"Direct Measurement of GFR: Who, When, and How?: A Practical Approach Emphasizing Iohexol Plasma Clearance","volume":"37","author":"Schaeffner","year":"2026","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/liv.15134","article-title":"Estimated glomerular filtration rate by formulas in patients with cirrhosis: An unreliable procedure","volume":"42","author":"Porrini","year":"2022","journal-title":"Liver Int."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Stammler, F., Derain-Dubourg, L., Lemoine, S., Meeusen, J.W., Dasari, S., Lieske, J.C., Robertson, A., and Schiffer, E. (2023). Impact of race-independent equations on estimating glomerular filtration rate for the assessment of kidney dysfunction in liver disease. BMC Nephrol., 24.","DOI":"10.1186\/s12882-023-03136-y"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/00041552-199811000-00009","article-title":"Application of newer clearance techniques for the determination of glomerular filtration rate. Comparative Study","volume":"7","author":"Gaspari","year":"1998","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann. Intern. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0272-6386(12)81022-5","article-title":"Utility of radioisotopic filtration markers in chronic renal insufficiency: Simultaneous comparison of 125I-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin","volume":"16","author":"Perrone","year":"1990","journal-title":"Am. J. Kidney Dis. Off. J. Natl. Kidney Found."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0272-6386(97)90488-1","article-title":"GFR determined by nonradiolabeled iothalamate using capillary electrophoresis","volume":"30","author":"Wilson","year":"1997","journal-title":"Am. J. Kidney Dis. Off. J. Natl. Kidney Found."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jhep.2009.11.025","article-title":"The evaluation of renal function and disease in patients with cirrhosis","volume":"52","author":"Francoz","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/0002-9343(87)90156-2","article-title":"Unpredictability of clinical evaluation of renal function in cirrhosis","volume":"82","author":"Papadakis","year":"1987","journal-title":"Am. J. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/ndt\/gfh839","article-title":"Measured creatinine clearance from timed urine collections substantially overestimates glomerular filtration rate in patients with liver cirrhosis: A systematic review and individual patient meta-analysis","volume":"20","author":"Proulx","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1053\/ajkd.2003.50035","article-title":"Assessing renal function in cirrhotic patients: Problems and pitfalls. Review","volume":"41","author":"Sherman","year":"2003","journal-title":"Am. J. Kidney Dis. Off. J. Natl. Kidney Found."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/ckj\/sfad050","article-title":"Average creatinine-urea clearance: Revival of an old analytical technique?","volume":"16","author":"Selistre","year":"2023","journal-title":"Clin. Kidney J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/lt.20017","article-title":"Estimation of glomerular filtration rates before and after orthotopic liver transplantation: Evaluation of current equations","volume":"10","author":"Gonwa","year":"2004","journal-title":"Liver Transplant."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/clinchem\/48.6.850","article-title":"Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis","volume":"48","author":"Orlando","year":"2002","journal-title":"Clin. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"785","DOI":"10.7326\/0003-4819-156-11-201203200-00391","article-title":"Estimating equations for glomerular filtration rate in the era of creatinine standardization: A systematic review","volume":"156","author":"Earley","year":"2012","journal-title":"Ann. Intern. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.3748\/wjg.v17.i40.4532","article-title":"Difference between CKD-EPI and MDRD equations in calculating glomerular filtration rate in patients with cirrhosis. Evaluation Studies","volume":"17","author":"Chen","year":"2011","journal-title":"World J. Gastroenterol. WJG"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/MEG.0b013e32834991f1","article-title":"Creatinine-based glomerular filtration rate estimation in patients with liver disease: The new Chronic Kidney Disease Epidemiology Collaboration equation is not better. Comparative Study Evaluation Studies","volume":"23","author":"Gerhardt","year":"2011","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0749-0704(18)30058-7","article-title":"Nutritional support during liver failure. Review","volume":"11","author":"Gecelter","year":"1995","journal-title":"Crit. Care Clin."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/ki.1990.182","article-title":"Measurement of renal function in chronic renal disease","volume":"38","author":"Levey","year":"1990","journal-title":"Kidney Int."},{"key":"ref_75","first-page":"342","article-title":"Glomerular filtration rate measurement in cirrhotic patients with renal failure","volume":"50","author":"Roy","year":"1998","journal-title":"Clin. Nephrol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1042\/cs1020091","article-title":"Cimetidine administration and tubular creatinine secretion in patients with compensated cirrhosis","volume":"102","author":"Sansoe","year":"2002","journal-title":"Clin. Sci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.clinbiochem.2011.11.008","article-title":"Limitations of compensated Jaffe creatinine assays in cirrhotic patients","volume":"45","author":"Kuster","year":"2012","journal-title":"Clin. Biochem."},{"key":"ref_78","first-page":"79","article-title":"Role of routine estimation of creatinine clearance in patients with liver cirrhosis","volume":"13","author":"Amarapurkar","year":"1994","journal-title":"Indian J. Gastroenterol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1365-2036.2007.03443.x","article-title":"Review article: Renal function assessment in cirrhosis\u2014Difficulties and alternative measurements","volume":"26","author":"Cholongitas","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/hep.26704","article-title":"Glomerular filtration rate equations for liver-kidney transplantation in patients with cirrhosis: Validation of current recommendations","volume":"59","author":"Francoz","year":"2014","journal-title":"Hepatology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinbiochem.2004.09.025","article-title":"Cystatin C as a marker of GFR--history, indications, and future research","volume":"38","author":"Filler","year":"2005","journal-title":"Clin. Biochem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/gut.50.1.106","article-title":"Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver","volume":"50","author":"Gerbes","year":"2002","journal-title":"Gut"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2215\/CJN.03400410","article-title":"Comparison of cystatin C and creatinine-based glomerular filtration rate formulas with 51Cr-EDTA clearance in patients with cirrhosis","volume":"6","author":"Xirouchakis","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0009-8981(01)00546-0","article-title":"Diagnostic value of serum cystatin C for evaluation of hepatorenal syndrome","volume":"311","author":"Demirtas","year":"2001","journal-title":"Clin. Chim. Acta"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/lt.20422","article-title":"Early detection of acute renal failure by serum cystatin C: A new opportunity for a hepatologist","volume":"11","author":"Mazur","year":"2005","journal-title":"Liver Transplant."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/003655102753611753","article-title":"Plasma cystatin C as a marker of renal function in patients with liver cirrhosis","volume":"62","author":"Randers","year":"2002","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1515\/CCLM.2007.130","article-title":"Analysis of glomerular filtration rate, serum cystatin C levels, and renal resistive index values in cirrhosis patients","volume":"45","author":"Ustundag","year":"2007","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/clinchem\/46.5.712","article-title":"Correlation of serum concentrations of cystatin C and creatinine to inulin clearance in liver cirrhosis","volume":"46","author":"Woitas","year":"2000","journal-title":"Clin. Chem."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/liv.13600","article-title":"Cystatin C predicts acute kidney injury and mortality in cirrhotics: A prospective cohort study","volume":"38","author":"Maiwall","year":"2018","journal-title":"Liver Int."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1097\/TP.0000000000003222","article-title":"Cystatin C and Sarcopenia Predict Acute on Chronic Liver Failure Development and Mortality in Patients on the Liver Transplant Waiting List","volume":"104","author":"Mauro","year":"2020","journal-title":"Transplantation"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/hep.29290","article-title":"Plasma cystatin C is a predictor of renal dysfunction, acute-on-chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis","volume":"66","author":"Markwardt","year":"2017","journal-title":"Hepatology"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1111\/liv.14631","article-title":"Prognosis predictability of serum and urine renal markers in patients with decompensated cirrhosis: A multicentre prospective study","volume":"40","author":"Kim","year":"2020","journal-title":"Liver Int."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Teaford, H.R., Barreto, J.N., Vollmer, K.J., Rule, A.D., and Barreto, E.F. (2020). Cystatin C: A Primer for Pharmacists. Pharmacy, 8.","DOI":"10.3390\/pharmacy8010035"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1093\/ndt\/gfg349","article-title":"A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate","volume":"18","author":"Hoek","year":"2003","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/00365510410003723","article-title":"Calculation of glomerular filtration rate expressed in mL\/min from plasma cystatin C values in mg\/L","volume":"64","author":"Larsson","year":"2004","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/jgh.13446","article-title":"Comparison of creatinine and cystatin formulae with (51) Chromium-ethylenediaminetetraacetic acid glomerular filtration rate in patients with decompensated cirrhosis","volume":"32","author":"Cholongitas","year":"2017","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.cgh.2015.06.021","article-title":"Estimation of Glomerular Filtration Rate in Patients with Cirrhosis by Using New and Conventional Filtration Markers and Dimethylarginines","volume":"14","author":"Mindikoglu","year":"2016","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/ndt\/gfi305","article-title":"Calculation of glomerular filtration rate based on cystatin C in cirrhotic patients","volume":"21","author":"Poge","year":"2006","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/hep.26886","article-title":"Creatinine- versus cystatine C-based equations in assessing the renal function of candidates for liver transplantation with cirrhosis","volume":"59","author":"Dolomanova","year":"2014","journal-title":"Hepatology"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Krones, E., Fickert, P., Zitta, S., Artinger, K., Reibnegger, G., Durchschein, F., Wagner, D., Stojakovic, T., Stadlbauer, V., and Fauler, G. (2015). The chronic kidney disease epidemiology collaboration equation combining creatinine and cystatin C accurately assesses renal function in patients with cirrhosis. BMC Nephrol., 16.","DOI":"10.1186\/s12882-015-0188-0"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/hep.26556","article-title":"Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis","volume":"59","author":"Mindikoglu","year":"2014","journal-title":"Hepatology"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/hep.30321","article-title":"A Model for Glomerular Filtration Rate Assessment in Liver Disease (GRAIL) in the Presence of Renal Dysfunction","volume":"69","author":"Asrani","year":"2019","journal-title":"Hepatology"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/lt.26310","article-title":"Impact of Race-Adjusted Glomerular Filtration Rate Estimation on Eligibility for Simultaneous Liver-Kidney Transplantation","volume":"28","author":"Panchal","year":"2022","journal-title":"Liver Transplant."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.26980","article-title":"Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury","volume":"60","author":"Belcher","year":"2014","journal-title":"Hepatology"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.2215\/CJN.09430913","article-title":"Urinary biomarkers and progression of AKI in patients with cirrhosis","volume":"9","author":"Belcher","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.cgh.2016.11.035","article-title":"Urine Interleukin 18 and Lipocalin 2 Are Biomarkers of Acute Tubular Necrosis in Patients with Cirrhosis: A Systematic Review and Meta-analysis","volume":"15","author":"Puthumana","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hep.30592","article-title":"Neutrophil Gelatinase-Associated Lipocalin for Assessment of Acute Kidney Injury in Cirrhosis: A Prospective Study","volume":"70","author":"Huelin","year":"2019","journal-title":"Hepatology"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/lt.26344","article-title":"Role of Novel Kidney Biomarkers in Patients with Cirrhosis and After Liver Transplantation","volume":"28","author":"Asrani","year":"2022","journal-title":"Liver Transplant."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1016\/j.cgh.2022.08.033","article-title":"AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients with Cirrhosis: Expert Review","volume":"20","author":"Flamm","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/hep.28891","article-title":"Development and validation of a mathematical equation to estimate glomerular filtration rate in cirrhosis: The royal free hospital cirrhosis glomerular filtration rate","volume":"65","author":"Kalafateli","year":"2017","journal-title":"Hepatology"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/hep.30932","article-title":"MELD-GRAIL-Na: Glomerular Filtration Rate and Mortality on Liver-Transplant Waiting List","volume":"71","author":"Asrani","year":"2020","journal-title":"Hepatology"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/ajg.2013.466","article-title":"The Royal Free Hospital score: A calibrated prognostic model for patients with cirrhosis admitted to intensive care unit. Comparison with current models and CLIF-SOFA score","volume":"109","author":"Theocharidou","year":"2014","journal-title":"Am. J. Gastroenterol."},{"key":"ref_114","first-page":"195","article-title":"Evaluation of the Royal Free Hospital Cirrhosis Glomerular Filtration Rate Formula in Hispanic Patients with Cirrhosis: An External Validation","volume":"71","author":"Torre","year":"2019","journal-title":"Rev. Investig. Clin."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/MEG.0000000000001935","article-title":"Estimation of glomerular filtration rate in patients with cirrhosis: Evaluation of equations currently used in clinical practice and validation of Royal Free Hospital cirrhosis glomerular filtration rate","volume":"34","author":"Protopapas","year":"2022","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1186\/cc11188","article-title":"Hepatorenal syndrome: The 8th international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group","volume":"16","author":"Nadim","year":"2012","journal-title":"Crit. Care"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.ekir.2024.02.1397","article-title":"Clinical Presentation, Pathological Spectrum, and Outcomes of Alcoholic Cirrhosis-Related Immunoglobulin A Nephropathy","volume":"9","author":"Ronsin","year":"2024","journal-title":"Kidney Int. Rep."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1016\/j.kint.2022.07.013","article-title":"KDIGO 2022 Clinical Practice Guideline FOR the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease","volume":"102","author":"Jadoul","year":"2022","journal-title":"Kidney Int."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"e70731","DOI":"10.1002\/jmv.70731","article-title":"Glomerulonephritis, the Most Common Extrahepatic Manifestation Caused by Hepatitis B Virus Infection: Possible Pathogenesis and Therapeutic Approaches","volume":"97","author":"Lin","year":"2025","journal-title":"J. Med. Virol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jhep.2018.12.030","article-title":"Estimation of renal function in patients with liver cirrhosis: Impact of muscle mass and sex","volume":"70","author":"Yoo","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"105","author":"Stevens","year":"2024","journal-title":"Kidney Int."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/13\/2088\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T12:16:44Z","timestamp":1783081004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/13\/2088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":122,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["diagnostics16132088"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16132088","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]}}}